Presentation and outcomes for children with bone marrow necrosis and acute lymphoblastic leukemia: a literature review.

Loading...
Thumbnail Image

Date

2011-10

Journal Title

Journal ISSN

Volume Title

Repository Usage Stats

34
views
70
downloads

Citation Stats

Abstract

Bone marrow necrosis is a rare histopathology finding with the majority of cases occurring in the setting of a hematologic malignancy. This article reports a case of diffuse marrow necrosis in a child secondary to acute lymphoblastic leukemia and summarizes the clinical features and outcomes for children with bone marrow necrosis secondary to leukemia from 20 published reports. This review demonstrated that the most common presenting features were bone pain, fever, pancytopenia, and that outcomes were less favorable when compared with those without necrosis. However, contemporary literature suggests that outcomes are similar for children who have bone marrow necrosis secondary to leukemia when compared with overall survival rates for pediatric leukemia.

Department

Description

Provenance

Citation

Published Version (Please cite this version)

10.1097/mph.0b013e318223fe9b

Publication Info

Shah, Nirmish R, Daniel B Landi, Susan G Kreissman, Evan Kulbachi and Cassandra Moran (2011). Presentation and outcomes for children with bone marrow necrosis and acute lymphoblastic leukemia: a literature review. Journal of pediatric hematology/oncology, 33(7). pp. e316–e319. 10.1097/mph.0b013e318223fe9b Retrieved from https://hdl.handle.net/10161/24077.

This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.

Scholars@Duke

Shah

Nirmish Ramesh Shah

Associate Professor of Medicine
Landi

Daniel Bryce Landi

Assistant Professor of Pediatrics
Kreissman

Susan Gail Kreissman

Professor of Pediatrics

The emphasis of Dr Kreissman's clinical research involves the study of childhood neuroblastoma. Neuroblastoma is the most common extracranial solid tumor of childhood and this disease has a diverse clinical phenotype and prognosis. Dr Kreissman has developed, written, and served as national protocol chairman for 2 clinical trials designed to improve outcome for children with the high risk form of this disease through the Children's Oncology Group (COG). Results of this protocol have been published " A Randomized Study of Purged Versus Unpurged Peripheral Blood Stem Cell Transplant Following Dose Intensive Induction Therapy for High Risk Neuroblastoma" and established the new standard of using unpurged PBSC to support autologous transplant in high risk neuroblastoma. Dr. Kreissman has served as a member of the Neuroblastoma committees for COG. She was involved in designing and implimenting additional new protocols for the treatment of neuroblastoma.


Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.